[go: up one dir, main page]

PT92451A - Processo para a preparacao de composicoes farmaceuticas com efeito anti-inflamatorio contendo como ingrediente activo um 3,5-di-t-butil-4- hidroxifenil-1,3,4-tiadiazol ou oxadiazol ou 3,5-di-t-butil-4-hidroxifenil-1,2,4-tiadiazol, oxadiazol ou triazol - Google Patents

Processo para a preparacao de composicoes farmaceuticas com efeito anti-inflamatorio contendo como ingrediente activo um 3,5-di-t-butil-4- hidroxifenil-1,3,4-tiadiazol ou oxadiazol ou 3,5-di-t-butil-4-hidroxifenil-1,2,4-tiadiazol, oxadiazol ou triazol

Info

Publication number
PT92451A
PT92451A PT92451A PT9245189A PT92451A PT 92451 A PT92451 A PT 92451A PT 92451 A PT92451 A PT 92451A PT 9245189 A PT9245189 A PT 9245189A PT 92451 A PT92451 A PT 92451A
Authority
PT
Portugal
Prior art keywords
butyl
hydroxyphenyl
oxadiazol
thydiazol
acetyric
Prior art date
Application number
PT92451A
Other languages
English (en)
Other versions
PT92451B (pt
Inventor
Daniel Lee Flynn
David Thomas Connor
Paul Charles Unangst
Michael David Mullican
Michael William Wilson
Catherine Rose Kostlah
Gary Paul Shrum
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT92451A publication Critical patent/PT92451A/pt
Publication of PT92451B publication Critical patent/PT92451B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/13—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT92451A 1988-11-29 1989-11-29 Processo para a preparacao de composicoes farmaceuticas com efeito anti-inflamatorio contendo como ingrediente activo um 3,5-di-t-butil-4- hidroxifenil-1,3,4-tiadiazol ou oxadiazol ou 3,5-di-t-butil-4-hidroxifenil-1,2,4-tiadiazol, oxadiazol ou triazol PT92451B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27717188A 1988-11-29 1988-11-29
US42681489A 1989-10-30 1989-10-30

Publications (2)

Publication Number Publication Date
PT92451A true PT92451A (pt) 1990-05-31
PT92451B PT92451B (pt) 1995-07-18

Family

ID=26958349

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92451A PT92451B (pt) 1988-11-29 1989-11-29 Processo para a preparacao de composicoes farmaceuticas com efeito anti-inflamatorio contendo como ingrediente activo um 3,5-di-t-butil-4- hidroxifenil-1,3,4-tiadiazol ou oxadiazol ou 3,5-di-t-butil-4-hidroxifenil-1,2,4-tiadiazol, oxadiazol ou triazol

Country Status (16)

Country Link
EP (1) EP0371438B1 (pt)
JP (1) JP2821208B2 (pt)
KR (1) KR970004914B1 (pt)
AT (1) ATE127116T1 (pt)
AU (1) AU631385B2 (pt)
CA (1) CA2004154C (pt)
DE (1) DE68924044T2 (pt)
DK (1) DK599789A (pt)
ES (1) ES2075845T3 (pt)
FI (1) FI93954C (pt)
GR (1) GR3017688T3 (pt)
IE (1) IE68850B1 (pt)
NO (1) NO178623C (pt)
NZ (1) NZ231534A (pt)
PH (1) PH27025A (pt)
PT (1) PT92451B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102897A (en) * 1990-03-27 1992-04-07 Warner-Lambert Company 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues
US5143929A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
US5114958A (en) * 1991-05-09 1992-05-19 Warner-Lambert Company 1,2,4-oxadiazole and 1,2,4-thiadiazole derivatives of fenamates as antiinflammatory agents
DE69301894T2 (de) * 1992-10-28 1996-11-07 Shionogi & Co Benzylidenderivate
FI951367A (fi) * 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
MX9705557A (es) * 1995-01-23 1997-10-31 Lilly Co Eli Metodo y composiciones para el tratamiento de la esclerosis multiple.
WO1999020617A1 (en) * 1997-10-21 1999-04-29 Active Biotech Ab Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
UA66401C2 (en) 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
EP1440968A1 (en) * 1999-10-13 2004-07-28 Fmc Corporation Process to prepare aryltriazolinones and novel intermediates thereto
US6492527B1 (en) * 1999-10-13 2002-12-10 Fmc Corporation Process to prepare aryltriazolinones and novel intermediates thereto
SE0301232D0 (sv) * 2003-04-25 2003-04-25 Astrazeneca Ab Novel use
FR2883745A1 (fr) * 2005-04-01 2006-10-06 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2006103119A2 (en) * 2005-04-01 2006-10-05 Galderma Research & Development Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
WO2006103345A1 (fr) * 2005-04-01 2006-10-05 Galderma Research & Development Inhibiteurs de la tyrosinase et leur utilisation pour traiter les desordres hyperpigmentaires
FR2883875A1 (fr) * 2005-04-01 2006-10-06 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
DE102008038220A1 (de) * 2008-08-18 2010-02-25 Merck Patent Gmbh Oxadiazolderivate
WO2011028651A1 (en) * 2009-09-01 2011-03-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of human 15-lipoxygenase-1
US8580805B2 (en) * 2010-08-31 2013-11-12 Hubert Maehr Pyrimidine carboxamide derivatives
CN103102348B (zh) * 2011-11-14 2016-06-08 上海交通大学 噁二唑类化合物及其制备方法、药物组合物及其用途
CL2012003253A1 (es) * 2012-11-22 2013-01-11 Univ Concepcion Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
RS64931B1 (sr) 2019-06-18 2023-12-29 Pfizer Derivati benzizoxazol sulfonamida

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215949B1 (pt) * 1973-02-01 1976-07-02 Delalande Sa
US4212970A (en) * 1977-11-28 1980-07-15 Fuji Photo Film Co., Ltd. 2-Halomethyl-5-vinyl-1,3,4-oxadiazole compounds
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
DE3302120A1 (de) * 1983-01-22 1984-07-26 Bayer Ag, 5090 Leverkusen (+)-antipode des (e)-1-cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
GR862081B (en) * 1985-08-09 1986-12-24 Lilly Co Eli Di-t-butylphenol compounds
US4743606A (en) * 1986-03-25 1988-05-10 Boehringer Ingelheim Pharmaceuticals, Inc. 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties
US4758578A (en) * 1987-01-29 1988-07-19 Hoechst Roussel Pharmaceuticals, Inc. Arylthiadiazolylsulfonamides, pharmaceutical compositions and use
WO1989006125A1 (en) * 1987-12-31 1989-07-13 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols

Also Published As

Publication number Publication date
IE68850B1 (en) 1996-07-24
CA2004154C (en) 1997-10-07
DK599789D0 (da) 1989-11-28
NZ231534A (en) 1992-02-25
CA2004154A1 (en) 1990-05-29
FI93954B (fi) 1995-03-15
KR970004914B1 (ko) 1997-04-08
DE68924044D1 (de) 1995-10-05
PT92451B (pt) 1995-07-18
AU4562589A (en) 1990-06-21
NO894742D0 (no) 1989-11-28
FI895669A0 (fi) 1989-11-27
ATE127116T1 (de) 1995-09-15
GR3017688T3 (en) 1996-01-31
ES2075845T3 (es) 1995-10-16
DE68924044T2 (de) 1996-02-15
IE893785L (en) 1990-05-29
AU631385B2 (en) 1992-11-26
EP0371438A3 (en) 1991-03-27
FI93954C (fi) 1995-06-26
EP0371438B1 (en) 1995-08-30
NO894742L (no) 1990-05-30
DK599789A (da) 1990-05-30
NO178623B (no) 1996-01-22
NO178623C (no) 1996-05-02
EP0371438A2 (en) 1990-06-06
KR900007818A (ko) 1990-06-02
JP2821208B2 (ja) 1998-11-05
PH27025A (en) 1993-02-01
JPH02270865A (ja) 1990-11-05

Similar Documents

Publication Publication Date Title
PT92451A (pt) Processo para a preparacao de composicoes farmaceuticas com efeito anti-inflamatorio contendo como ingrediente activo um 3,5-di-t-butil-4- hidroxifenil-1,3,4-tiadiazol ou oxadiazol ou 3,5-di-t-butil-4-hidroxifenil-1,2,4-tiadiazol, oxadiazol ou triazol
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
KR870700620A (ko) 신규 약리학적 화합물
SE9402558D0 (sv) Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma
ES2071725T3 (es) Diesteres fosfato de acido ascorbico y tocoferilo para la inhibicion de la reaccion de maillard.
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
BR9807950A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições humanas, o risco de doença inflamatória o risco da dor e para a preparação de um composto
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
GR3005779T3 (pt)
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
CA2139731A1 (en) 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
PT98773A (pt) Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem
ES8609286A1 (es) Un metodo para preparar un compuesto de morfolinol
ATE16150T1 (de) Xanthinoxydasehemmer und verwendung von benztriazinderivaten.
JPS5545681A (en) 88chloroo66hydroxyy55methylbenzoic acid derivative
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
BR9808546A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições do ser humano, tratar ou reduzir o risco de doença inflamatória e o risco da dor em uma pessoa que sofre, ou em risco, da dita doença e para a preparação do composto
ATE95697T1 (de) Uricosuretische zusammensetzung.
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Effective date: 20050908